Transactions UK

Law360 UK Transactions delivers daily news, real-time alerts and forward-thinking analysis on corporate transactions trends and deals in the U.K. and EU including hostile takeovers, friendly mergers, IPOs, buyouts and shareholder disputes – and the laws and regulation surrounding them.

This essential newswire is a daily must-read for successful transactions lawyers to keep up with the latest deals and dealmakers, make informed business decisions and capitalize on opportunities as they unfold.



Sign up for a 7-day FREE trial today!



Latest News in Transactions UK

  • April 15, 2024

    Avoiding Legal Pitfalls In M&A Deferred Pricing Deals

    One of the worst markets for M&A dealmaking in a decade has spawned innovative pricing models such as deferred consideration arrangements for buyers and sellers to come to terms. But lawyers have told Law360 that these agreements have to be watertight to protect against future litigation.

  • April 12, 2024

    EU Approves Biotech Co. Illumina's Plan To Divest Grail

    European Union antitrust authorities on Friday approved Illumina's plan to sell off Grail, the latest development in a saga that saw the biotech company reverse course and agree to offload the cancer-screening company after authorities claimed the reacquisition was completed "unlawfully."

  • April 12, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen footwear brand Dr. Martens hit online retailer Temu with a passing off claim, Welsh soccer club Swansea sue its former head coach Russell Martin, Russian diamond tycoon Dmitry Tsvetkov file a claim against his former business Equix Group Ltd., and U.S. bank Omega Financial Corporation hit African oil and gas company Tende Energy with a claim. Here, Law360 looks at these and other new claims in the U.K.

  • April 12, 2024

    Abbott Loses Bid To Nix UK Whistleblowing Case On Appeal

    An appeals tribunal has rejected Abbott Laboratories' bid to escape a whistleblowing case brought by the founders of a British DNA technology business that it bought, concluding on Friday that the founders had an arguable case that U.K. judges had jurisdiction.

  • April 12, 2024

    French Bioscience Biz Raises €3M For New Drug Trials

    NFL Biosciences said Friday it had successfully raised approximately €3.1 million ($3.3 million) by issuing shares to investors to raise cash for new drug trials.

See more Transactions UK news

Intellectual Property

Areas of Coverage

  • MERGERS, ACQUISITIONS & DISPOSALS:
  • Share swaps & cash acquisitions
  • IPOs, Cash Calls and Buybacks
  • Management buy-outs and buy-ins
  • Leveraged-buyouts
  • Shareholder agreements & Poison Pills
  • Activist shareholders and proxy fights
  • Venture capital and private equity deals
  • Distressed M&A: insolvency, restructuring, bailouts
  • AGENCIES
  • The Competition and Markets Authority
  • The Financial Conduct Authority
  • The Pension Regulator
  • POLICY & REGULATION
  • U.K. Takeover Code under the Companies Act
  • Financial Services and Markets Act
  • Market Abuse Regulation
  • The Enterprise Act

Readership

  • M&A lawyers
  • Commercial disputes lawyers at top law firms
  • Executives and attorneys at insurance companies and corporate policyholders
  • Corporate counsel and compliance officers at Fortune 1000 and FTSE 350 companies
  • Information experts at law firms, agencies and companies
  • Judges and court staff across the U.K.
  • Attorney and law firm marketing professionals
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!